Panagora Asset Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $367K | Buy |
+38,948
| New | +$428K | ﹤0.01% | 924 |
|
|
2025
Q2 | – | Sell |
-44,592
| Closed | -$981K | – | 1155 |
|
|
2025
Q1 | $981K | Sell |
44,592
-2,419
| -5% | -$56.9K | ﹤0.01% | 666 |
|
|
2024
Q4 | $1.07M | Buy |
+47,011
| New | +$1.03M | ﹤0.01% | 643 |
|
|
2024
Q2 | – | Sell |
-6,270
| Closed | -$222K | – | 1241 |
|
|
2024
Q1 | $222K | Buy |
6,270
+470
| +8% | +$18.8K | ﹤0.01% | 1138 |
|
|
2023
Q4 | $253K | Sell |
5,800
-37
| -0.6% | -$1.46K | ﹤0.01% | 1128 |
|
|
2023
Q3 | $223K | Buy |
+5,837
| New | +$246K | ﹤0.01% | 1148 |
|
|
2023
Q2 | – | Sell |
-4,513
| Closed | -$259K | – | 1359 |
|
|
2023
Q1 | $259K | Sell |
4,513
-358
| -7% | -$20.2K | ﹤0.01% | 1300 |
|
|
2022
Q4 | $273K | Buy |
+4,871
| New | +$248K | ﹤0.01% | 1303 |
|
|
2021
Q4 | – | Sell |
-3,583
| Closed | -$245K | – | 1625 |
|
|
2021
Q3 | $245K | Hold |
3,583
| – | – | ﹤0.01% | 1582 |
|
|
2021
Q2 | $245K | Sell |
3,583
-179
| -5% | -$12.7K | ﹤0.01% | 1605 |
|
|
2021
Q1 | $260K | Buy |
3,762
+1,589
| +73% | +$108K | ﹤0.01% | 1608 |
|
|
2020
Q4 | $141K | Sell |
2,173
-208
| -9% | -$11.2K | ﹤0.01% | 1725 |
|
|
2020
Q3 | $112K | Buy |
2,381
+61
| +3% | +$2.9K | ﹤0.01% | 1760 |
|
|
2020
Q2 | $109K | Buy |
2,320
+39
| +2% | +$1.92K | ﹤0.01% | 1758 |
|
|
2020
Q1 | $102K | Sell |
2,281
-150,724
| -99% | -$7.91M | ﹤0.01% | 1692 |
|
|
2019
Q4 | $8.92M | Sell |
153,005
-36,318
| -19% | -$2.16M | 0.04% | 353 |
|
|
2019
Q3 | $11.4M | Buy |
189,323
+187,252
| +9,042% | +$11.2M | 0.05% | 299 |
|
|
2019
Q2 | $116K | Hold |
2,071
| – | – | ﹤0.01% | 1931 |
|
|
2019
Q1 | $115K | Hold |
2,071
| – | – | ﹤0.01% | 1848 |
|
|
2018
Q4 | $93K | Buy |
2,071
+41
| +2% | +$2.25K | ﹤0.01% | 1825 |
|
|
2018
Q3 | $134K | Hold |
2,030
| – | – | ﹤0.01% | 1783 |
|
|
2018
Q2 | $131K | Hold |
2,030
| – | – | ﹤0.01% | 1779 |
|
|
2018
Q1 | $112K | Hold |
2,030
| – | – | ﹤0.01% | 1827 |
|
|
2017
Q4 | $97K | Hold |
2,030
| – | – | ﹤0.01% | 1884 |
|
|
2017
Q3 | $102K | Sell |
2,030
-115,633
| -98% | -$5.94M | ﹤0.01% | 1879 |
|
|
2017
Q2 | $6.41M | Sell |
117,663
-230,326
| -66% | -$11M | 0.03% | 509 |
|
|
2017
Q1 | $14.7M | Buy |
347,989
+8,623
| +3% | +$368K | 0.06% | 317 |
|
|
2016
Q4 | $14.6M | Sell |
339,366
-11,996
| -3% | -$488K | 0.07% | 295 |
|
|
2016
Q3 | $14.5M | Buy |
351,362
+13,492
| +4% | +$565K | 0.07% | 280 |
|
|
2016
Q2 | $13.5M | Sell |
337,870
-29,862
| -8% | -$1.07M | 0.07% | 287 |
|
|
2016
Q1 | $12.4M | Buy |
367,732
+6,228
| +2% | +$194K | 0.06% | 324 |
|
|
2015
Q4 | $12.3M | Buy |
361,504
+76,710
| +27% | +$2.4M | 0.06% | 307 |
|
|
2015
Q3 | $8.48M | Sell |
284,794
-7,882
| -3% | -$246K | 0.04% | 372 |
|
|
2015
Q2 | $8.06M | Buy |
292,676
+148,041
| +102% | +$3.95M | 0.04% | 404 |
|
|
2015
Q1 | $3.65M | Buy |
144,635
+50,933
| +54% | +$1.2M | 0.02% | 593 |
|
|
2014
Q4 | $2.08M | Buy |
93,702
+66,275
| +242% | +$1.34M | 0.01% | 742 |
|
|
2014
Q3 | $557K | Buy |
27,427
+14,150
| +107% | +$282K | ﹤0.01% | 1273 |
|
|
2014
Q2 | $255K | Sell |
13,277
-709
| -5% | -$13.2K | ﹤0.01% | 1634 |
|
|
2014
Q1 | $263K | Buy |
+13,986
| New | +$270K | ﹤0.01% | 1644 |
|
|
2013
Q4 | – | Sell |
-467
| Closed | -$8K | – | 2208 |
|
|
2013
Q3 | $8K | Sell |
467
-3,244
| -87% | -$52.1K | ﹤0.01% | 2269 |
|
|
2013
Q2 | $56K | Buy |
+3,711
| New | +$54.4K | ﹤0.01% | 1995 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Panagora Asset Management's IART Position: Q1 2026 in Review
Panagora Asset Management opened a new position in Integra LifeSciences (IART) in Q1 2026: 38,948 shares worth $367K. The stake represents ﹤0.01% of the portfolio and ranks #924 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in IART as recently as Q1 2025.
Panagora Asset Management first reported a position in IART in Q2 2013 and has held it in 41 quarters since. The position peaked at $14.7M in Q1 2017. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Panagora Asset Management held 38,948 shares of Integra LifeSciences worth $367K as of Q1 2026.
- Integra LifeSciences was a new Panagora Asset Management position in Q1 2026.
- Integra LifeSciences made up ﹤0.01% of Panagora Asset Management's portfolio in Q1 2026, its #924 holding.
- Panagora Asset Management first reported a position in Integra LifeSciences in Q2 2013 and has held it in 41 quarters since.
- Panagora Asset Management's Integra LifeSciences position peaked at $14.7M in Q1 2017.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.